65
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes

, , &
Pages 991-1002 | Published online: 11 Mar 2016

References

  • GordonRSkin cancer: an overview of epidemiology and risk factorsSemin Oncol Nurs201329316016923958214
  • ViolaJRRafaelDFWagnerEBeschROgrisMGene therapy for advanced melanoma: selective targeting and therapeutic nucleic acidsJ Drug Deliv2013201389734823634303
  • FormentiFConstantin-TeodosiuDEmmanuelYRegulation of human metabolism by hypoxia-inducible factorProc Natl Acad Sci U S A201010728127221272720616028
  • PouyssegurJDayanFMazureNMHypoxia signalling in cancer and approaches to enforce tumour regressionNature2006441709243744316724055
  • FolkmanJRole of angiogenesis in tumor growth and metastasisSemin Oncol200229151812516034
  • VasudevNSReynoldsARAnti-angiogenic therapy for cancer: current progress, unresolved questions and future directionsAngiogenesis201417347149424482243
  • NakazawaYKawanoSMatsuiJMultitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer modelCancer Sci2015106220120725458359
  • OzcanGOzpolatBColemanRLSoodAKLopez-BeresteinGPreclinical and clinical development of siRNA-based therapeuticsAdv Drug Deliv Rev2015298710811925666164
  • HannaSCKrishnanBBaileySTHIF1alpha and HIF2alpha independently activate SRC to promote melanoma metastasesJ Clin Invest201312352078209323563312
  • KuphalSWinklmeierAWarneckeCBosserhoffAKConstitutive HIF-1 activity in malignant melanomaEur J Cancer20104661159116920185296
  • BoeSLJorgensenJALongvaASLavelleTSaeboe-LarssenSHovigELight-controlled modulation of gene expression using polyamidoamine formulationsNucleic Acid Ther201323216016523530684
  • IslamMAParkTESinghBMajor degradable polycations as carriers for DNA and siRNAJ Control Release2014193748924942341
  • LiuYHeXKuangYA bacteria deriving peptide modified dendrigraft poly-l-lysines (DGL) self-assembling nanoplatform for targeted gene deliveryMol Pharm201411103330334124964270
  • AsayamaSKumagaiTKawakamiHSynthesis and characterization of methylated poly(L-histidine) to control the stability of its siRNA polyion complexes for RNAiBioconjug Chem20122371437144222681572
  • PlianwongSOpanasopitPNgawhirunpatTRojanarataTChitosan combined with poly-L-arginine as efficient, safe, and serum-insensitive vehicle with RNase protection ability for siRNA deliveryBiomed Res Int2013201357413623865058
  • LiuYTaoJLiYTargeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growthMol Ther200917226927719066596
  • SafinyaCREwertKKMajzoubRNLealCCationic liposome-nucleic acid complexes for gene delivery and gene silencingNew J Chem2014381151645172
  • HattoriYNakamuraAAraiSKawanoKMaitaniYYonemochiEsiRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomesJ Liposome Res201425427928625543847
  • PirolloKFZonGRaitATumor-targeting nanoimmunoliposome complex for short interfering RNA deliveryHum Gene Ther200617111712416409130
  • WangBZhangSCuiSChitosan enhanced gene delivery of cationic liposome via non-covalent conjugationBiotechnol Lett2012341192822009568
  • XiaZWuSChenJPreparation of water soluble chitosan by hydrolysis using hydrogen peroxideInt J Biol Macromol20135924224523603076
  • PuskasISzemjonovAFenyvesiEMalangaMSzenteLAspects of determining the molecular weight of cyclodextrin polymers and oligomers by static light scatteringCarbohydr Polym201394112412823544520
  • ZhangJChenXGHuangLHanJTZhangXFSelf-assembled polymeric nanoparticles based on oleic acid-grafted chitosan oligosaccharide: biocompatibility, protein adsorption and cellular uptakeJ Mater Sci Mater Med20122371775178322555502
  • ZhongXLinRLiZMaoJChenLEffects of Salidroside on cobalt chloride-induced hypoxia damage and mTOR signaling repression in PC12 cellsBiol Pharm Bull20143771199120624989011
  • ZhangXZhangTYeYPhospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effectEur J Pharm Biopharm201594304125936860
  • HanNRLeeHBaekSYunJIParkKHLeeSTDelivery of episomal vectors into primary cells by means of commercial transfection reagentsBiochem Biophys Res Commun2015461234835325887802
  • MartinTMPlautzSAPannierAKTemporal endogenous gene expression profiles in response to lipid-mediated transfectionJ Gene Med2015171–2143225663588
  • LiHMitevaMKirkbrideKCDual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA deliveryBiomacromolecules201516119220125414930
  • Sanchez-del-CampoLMontenegroMFCabezas-HerreraJRodriguez-LopezJNThe critical role of alpha-folate receptor in the resistance of melanoma to methotrexatePigment Cell Melanoma Res200922558860019493312
  • MotoyamaKOnoderaRTanakaNEvaluation of antitumor effects of folate-conjugated methyl-beta-cyclodextrin in melanomaBiol Pharm Bull201538337437925757918
  • NutschKHsiehCWhen T cells run out of breath: the HIF-1α storyCell2011146567367421884928
  • LeeJWBaeSHJeongJWKimSHKimKWHypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functionsExp Mol Med200436111215031665
  • LiuXQXiongMHShuXTTangRZWangJTherapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growthMol Pharm20129102863287422924580
  • LiTSYawataTHonkeKEfficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapyEur J Pharm Sci201452486124178005
  • ZalaDHinckelmannMVYuHVesicular glycolysis provides on-board energy for fast axonal transportCell2013152347949123374344